Cardiotoxicity During Long-Term Trastuzumab Use in Patients with HER2-positive Metastatic Breast Cancer: Who Needs Cardiac Monitoring?
Breast Cancer Research and Treatment(2021)
Key words
HER2-positive metastatic breast cancer,Trastuzumab treatment,Cardiotoxicity,LVEF monitoring,Screening for cardiotoxicity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined